CCL2/MCP-1, interleukin-8, and fractalkine/CXC3CL1: Potential biomarkers of epileptogenesis and pharmacoresistance in childhood epilepsy

EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY

Ceská, K; Papez, J; Oslejsková, H; Slaby, O; Radová, L; Loja, T; Libá, Z; Sveráková, A; Brázdil, M; Aulická, S, 2023: CCL2/MCP-1, interleukin-8, and fractalkine/CXC3CL1: Potential biomarkers of epileptogenesis and pharmacoresistance in childhood epilepsy. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY 46, p. 48 - 54, doi: 10.1016/j.ejpn.2023.06.001

Research Groups:

Molecular Oncology - Solid Cancer
CF: Genomics Core Facility
Medical Genomics

CEITEC authors:

Prof. Ondřej Slabý, Ph.D.
Lenka Radová, Ph.D.
Štefánia Aulická, Ph.D.
Tomáš Loja, Ph.D.